Waltham, MA (PRWEB) April 04, 2014
OpenClinica, LLC announces that Tasly Pharmaceuticals Inc. has selected the OpenClinica Enterprise Edition for clinical trial electronic data capture (EDC) and clinical data management. Tasly Pharmaceuticals is a research-driven group invested in the development and distribution of modern TCM (Traditional Chinese Medicine) throughout key markets across Southeast Asia, Europe, North America and Africa.
“We are impressed with the flexibility and cost effectiveness of OpenClinica,” said Henry Sun, President & CEO of Tasly Pharmaceuticals, Inc. “OpenClinica will be an instrumental tool for us as Tasly develops new treatments for the marketplace.”
The OpenClinica software is available in two editions. The OpenClinica Community Edition is freely available under the LGPL open source license. The OpenClinica Enterprise Edition is commercially supported software-as-a-service by OpenClinica, LLC ideal for running mission critical clinical studies.
About Tasly Pharmaceuticals
Tasly Pharmaceuticals, a member of the Tianjin Tasly Pharmaceutical Co. is a leading traditional Chinese medicine (TCM) provider with an extensive portfolio comprising medication against viral infections, tumors, cardiovascular and cerebrovascular conditions, and remedies strengthening the immune and digestive systems. Tasly’s scientific initiatives translate into 40 research programs across China and partnerships with international academic and research institutions, among which Harvard University. For more information, visit http://www.tasly.com.
About OpenClinica, LLC
OpenClinica, LLC enhances the productivity of clinical trials through commercial open source software. With thousands of implementations at biopharmaceutical companies, contract research organizations, academic, and government organizations worldwide, the OpenClinica software facilitates electronic data capture and data management, increasing the speed of collection and quality of data in clinical trials. OpenClinica supports HIPAA, 21 CFR Part 11, and other regulatory guidelines and is designed as a standards-based, extensible, and modular platform. For more information, visit openclinica.com.